Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease.
about
The utility of neuroimaging in the differential diagnosis of parkinsonian syndromesBrain Magnetic Resonance Imaging (MRI) as a Potential Biomarker for Parkinson's Disease (PD).Neuromelanin magnetic resonance imaging reveals increased dopaminergic neuron activity in the substantia nigra of patients with schizophrenia.Parkinson's disease, lights and melanocytes: looking beyond the retina.A multicontrast approach for comprehensive imaging of substantia nigra.Quantitative T1, T2, and T2* Mapping and Semi-Quantitative Neuromelanin-Sensitive Magnetic Resonance Imaging of the Human Midbrain.Neuromelanin in parkinsonian disorders: an update.Neuromelanin Imaging and Dopaminergic Loss in Parkinson's DiseaseA Comparison of Substantia Nigra T1 Hyperintensity in Parkinson's Disease Dementia, Alzheimer's Disease and Age-Matched Controls: Volumetric Analysis of Neuromelanin ImagingNeuromelanin MRI is useful for monitoring motor complications in Parkinson's and PARK2 disease.Diffusion tensor imaging of the substantia nigra in Parkinson's disease revisited.Multimodal MRI assessment of nigro-striatal pathway in multiple system atrophy and Parkinson disease.3D neuromelanin-sensitive magnetic resonance imaging with semi-automated volume measurement of the substantia nigra pars compacta for diagnosis of Parkinson's disease.[(18)F]AV-1451 binding to neuromelanin in the substantia nigra in PD and PSP.Magnetic Resonance Imaging Biomarkers to Assess Substantia Nigra Damage in Idiopathic Rapid Eye Movement Sleep Behavior Disorder.Iron metabolism and its detection through MRI in parkinsonian disorders: a systematic review.Substantia nigra neuromelanin-MR imaging differentiates essential tremor from Parkinson's disease.Automated neuromelanin imaging as a diagnostic biomarker for Parkinson's disease.Substantia nigra neuromelanin magnetic resonance imaging in de novo Parkinson's disease patients.Contrast mechanisms associated with neuromelanin-MRI.Magnetic resonance correlation of iron content with neuromelanin in the substantia nigra of early-stage Parkinson's disease.Correlation between pathology and neuromelanin MR imaging in Parkinson's disease and dementia with Lewy bodies.Quantitative Analysis Versus Visual Assessment of Neuromelanin MR Imaging for the Diagnosis of Parkinson's disease.Correlation between neuromelanin-sensitive MR imaging and (123)I-FP-CIT SPECT in patients with parkinsonism.Evaluation of Parkinson disease and Alzheimer disease with the use of neuromelanin MR imaging and (123)I-metaiodobenzylguanidine scintigraphy.Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism
P2860
Q27025731-F61D9FA5-B898-4B6F-8A27-2E845DF6D77CQ33831798-784F1108-70E9-4211-9701-364F868085E6Q34028030-0A8F0FE0-CB5E-480E-B663-30CA3DA93AC1Q34400617-75C76DE0-0B3F-4A46-B176-31EF6DDD82ABQ35555926-4A47B70B-7FB3-4424-987A-C6F6533CBE78Q36171001-6D5EF2DA-34BE-47F8-A7E9-6F48A2C768BAQ36359956-63EC0815-3388-4A26-9060-F2C8A7C0B898Q37192855-C16B220D-CA82-49E7-9CDB-47C40C44D0FCQ37223082-6FE97678-E89C-41DD-AF34-10D7698E60EBQ39119095-158D220B-D1E0-4BC3-ADFE-C55698FB472AQ39877122-D798274A-671E-4BDE-B0A8-5E31F3F6BADFQ40202363-855CC270-58DD-49D6-AF76-97DA85F6FDA5Q43720718-4D0F8661-9848-44DE-A030-0E6F6BFA67B8Q47627080-FC2E318D-D1C1-4C27-9443-6DE0EE3B338CQ47680043-485B57B2-EAF0-400B-AE70-8FC28A1F8379Q48129184-EB04E6C9-61A6-413C-9C82-E43A0A7049C6Q48217638-E316105C-AAFB-4DA5-A08B-A3773A8A678BQ48280181-B18F20B0-92C2-45AA-BBC9-497369B9F2E2Q48402405-603DD190-842F-4881-AB84-E3054DBFCEB6Q48718497-8011945B-216F-487B-BE29-4312B39D047AQ50243985-6C079DDE-8617-4997-8E5B-6A2690C197F4Q51217722-6516134A-CED4-41FC-8E19-CAB7C59B3716Q52148846-E4B7373C-AAAC-4878-9553-FE47C45F3B73Q52985613-57B7C9B8-858A-4C6A-8B91-06F47E103E12Q53452154-B39A9DC0-72CA-4894-BA28-629EF55086EFQ58576300-F76AC7EE-CEA0-4E73-9097-5F1106A5E66D
P2860
Neuromelanin magnetic resonance imaging of nigral volume loss in patients with Parkinson's disease.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Neuromelanin magnetic resonanc ...... ents with Parkinson's disease.
@en
Neuromelanin magnetic resonanc ...... ents with Parkinson's disease.
@nl
type
label
Neuromelanin magnetic resonanc ...... ents with Parkinson's disease.
@en
Neuromelanin magnetic resonanc ...... ents with Parkinson's disease.
@nl
prefLabel
Neuromelanin magnetic resonanc ...... ents with Parkinson's disease.
@en
Neuromelanin magnetic resonanc ...... ents with Parkinson's disease.
@nl
P2093
P1476
Neuromelanin magnetic resonanc ...... ents with Parkinson's disease.
@en
P2093
Fumiyo Higaki
Kenichi Kashihara
Takayoshi Shinya
P304
P356
10.1016/J.JOCN.2010.08.043
P577
2011-06-29T00:00:00Z